Carl Johan Fredin, with many years of international experience from leading companies and positions in pharmaceuticals, MedTech and healthcare, has been recruited to a new role as Chief Licensing Officer. Carl Johan, whose most recent position was with Mölnlycke, will take up his new role on 1 October and report to the CEO. Carl Johan Fredin is 55 years old and has successfully led and developed teams in leading pharma and MedTech companies, including Glaxo Smith Kline, Janssen, Mundipharma, Doro and, most recently Mölnlycke. He has also been the CEO of Ortho Center in Gothenburg and Malmoe, as well as Sales and Marketing Director at Aleris.